Related Experiment Videos
Increased physiological dead space during exercise after bronchodilation in cystic fibrosis
G Kusenbach1, F Friedrichs, H Skopnik
1Department of Pediatrics, Technical University of Aachen, Federal Republic of Germany.
Pediatric Pulmonology
|May 1, 1993
Summary
Bronchodilators like salbutamol and theophylline may negatively impact exercise lung function in cystic fibrosis (CF) patients. Careful individual evaluation of these medications is essential for CF patients.
Area of Science:
- Pulmonary Medicine
- Exercise Physiology
Background:
- Cystic Fibrosis (CF) is a genetic disorder affecting lung function.
- Exercise is crucial for CF patients, but ventilatory responses can be challenging.
- The impact of bronchodilators on exercise physiology in CF requires further investigation.
Purpose of the Study:
- To evaluate the effects of salbutamol and theophylline on ventilatory response during exercise in CF patients.
- To determine if bronchodilator therapy impacts exercise performance and lung function.
- To assess the predictability of these effects using baseline lung function tests.
Main Methods:
- Bicycle ergospirometry was conducted on 14 CF patients.
- Patients exercised at 1/3 and 2/3 of their maximal working capacity (Wmax).
- Tests were performed without bronchodilators and after treatment with salbutamol, theophylline, or both.
Main Results:
- Combined therapy significantly increased physiological deadspace, ventilation, and ventilatory equivalents at 1/3 Wmax.
- Similar trends, though not statistically significant, were observed with monotherapy and at 2/3 Wmax.
- These exercise-related changes were not predictable by resting lung function or the Shwachman-Kulczycki score.
Conclusions:
- Bronchodilators can potentially impair lung function during exercise in some CF patients.
- The benefits of bronchodilators in CF patients undergoing exercise should be carefully evaluated individually.
- Medication effects on exercise performance are a critical consideration for CF management.